VRAX

Virax Biolabs Group Limited - Ordinary Shares (VRAX)

About Virax Biolabs Group Limited - Ordinary Shares (VRAX)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Details

Daily high

$3.89

Daily low

$3.52

Price at open

$3.66

52 Week High

$28.50

52 Week Low

$2.50

Market cap

3.0M

Dividend yield

0.00%

Volume

406,420

Avg. volume

4.8M

P/E ratio

-.22

Virax Biolabs Group Limited - Ordinary Shares News